Biolife solutions inc (BLFS)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,565,172

-1,265,975

-1,719,712

-1,490,513

-1,400,997

-1,291,719

-1,150,395

-1,152,265

-995,613

-862,455

-883,356

-559,371

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-12,238,000

9,316,000

838,000

427,000

-27,378,000

1,230,000

-3,730,000

3,000

4,873,000

-557,780

-318,718

-768,212

-870,290

-

-

-

-

-

-

-

-

-

-

-

-

-

-309,910

-282,506

-7,176

-511,588

-352,228

-498,893

-296,877

-411,170

-478,668

-436,679

-630,122

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation

345,000

164,000

111,000

98,000

93,000

84,000

83,000

78,000

78,000

79,105

83,644

86,702

89,549

91,756

92,453

92,102

91,791

87,670

86,821

85,081

83,646

72,014

63,380

60,219

62,506

63,822

64,988

59,565

58,697

59,626

50,641

32,922

26,455

26,342

24,580

23,321

22,872

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-431

0

63

-283

1,896

0

0

Stock-based compensation

1,136,000

655,000

646,000

606,000

388,000

383,000

375,000

373,000

373,000

312,289

313,943

313,873

329,895

193,147

181,084

256,236

146,527

174,827

178,259

124,862

33,509

46,178

74,325

57,557

51,619

72,417

88,234

20,171

67,382

61,347

57,134

50,925

46,688

52,183

51,787

53,242

78,628

Amortization of deferred rent related to lease incentives

-

0

0

0

-

32,000

31,000

32,000

-

31,751

31,750

31,749

31,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash lease expense

-644,000

45,000

44,000

43,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense – finance type lease

-

0

0

2,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

60,000

70,000

80,000

-

-

-

-

-

-

-

-

-

-

-

-

Stock to be issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Write off of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

13,022

14,262

14,263

14,107

13,952

18,397

18,396

14,701

27,045

121,464

-73,815

11,430

15,324

Amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-31,750

-31,750

-31,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

4

0

62,398

93,598

93,597

93,598

31,199

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from equity method investment in SAVSU

0

-291,000

-216,000

-232,000

-309,000

-42,000

-177,000

-144,000

-144,000

-297,792

-217,735

-260,105

-229,368

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-4,870,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

31,749

158,747

-31,750

-31,749

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease incentives received from landlord, net of amortization of deferred rent related to lease incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83,399

-40,966

-40,359

-39,778

-36,096

-35,563

137,154

-13,333

95,720

-19,030

785,112

0

-

-

-

-

Accretion and amortization on available for sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,792

-8,915

-15,725

-24,584

-40,901

-44,808

-33,558

-19,640

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in operating assets and liabilities
Accounts receivable, trade, net

-82,000

-260,000

750,000

-118,000

346,000

533,000

1,122,000

23,000

23,000

-331,851

180,461

112,263

-132,873

-117,360

26,991

93,755

260,971

137,015

-17,113

-41,657

-50,579

126,547

208,536

-759,024

316,248

835,868

-807,526

756,825

-376,004

197,790

-438,753

112,626

75,327

-88,466

-63,353

-38,623

-17,802

Inventories

2,047,000

389,000

790,000

551,000

598,000

789,000

285,000

-10,000

-10,000

-14,274

91,988

-43,102

54,388

221,714

-6,970

-107,526

183,620

51,252

462,126

78,470

277,563

247,600

39,468

381,051

-123,819

-482,675

310,461

-43,218

-20,041

192,814

67,599

-152,843

-258,011

-30,830

34,446

-62,266

-36,820

Prepaid expenses and other current assets

-

240,000

38,000

-6,000

-

-54,000

115,000

-12,000

-

79,521

-34,426

-2,124

138,029

-102,947

-20,459

67,475

-17,324

-101,597

134,167

24,394

-72,156

39,761

-6,993

79,316

-88,961

82,360

44,093

17,631

-27,070

-51,817

-46,257

-8,358

22,145

459

-24,373

11,252

-15,405

Accounts payable

391,000

413,000

-589,000

553,000

-354,000

175,000

237,000

-69,000

-69,000

248,732

-103,493

-112,269

-11,970

-128,418

154,531

115,462

91,907

-59,261

353,418

-320,817

221,046

305,824

-1,268

-537,877

-159,087

26,572

-201,219

-12,194

191,419

-201,791

532,667

-2,385

130,898

92,661

-36,621

70,548

159,447

Accrued compensation and other current liabilities

-

578,000

282,000

-302,000

-

201,000

105,000

-101,000

-

153,115

82,443

14,995

41,447

-302,565

-145,113

26,833

10,694

30,063

91,747

85,848

-353,077

193,006

138,495

87,227

-411,650

372,663

6,932

-38,093

-63,278

97,932

62,356

83,629

-16,199

-41,828

49,995

-31,620

-36,303

Accrued interest

-

-

-

-

-

-

-

-

-

-143

-33,274

102,084

83,333

58,333

31,191

8,333

0

-

-

-

-

-

0

0

177,308

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-3,000

-3,000

-

-1,164

-1,417

565

-62,984

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

185,555

185,554

185,555

185,555

185,555

185,555

183,543

178,777

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

3,448

4,612

6,594

13,335

6,932

8,049

16,685

4,966

57,516

-7,554

-5,226

-5,227

9,775

10,915

7,717

-27,412

29,821

46,189

6,134

-6,134

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,181,671

-1,593,483

-1,270,270

-1,168,630

-1,227,109

-1,307,852

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160,542

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-109,167

-5,000

-163,717

153,717

-5,000

-5,000

-5,000

-5,000

-5,000

Net cash provided by operating activities

-1,003,000

1,137,000

-67,000

1,146,000

585,000

810,000

561,000

392,000

392,000

802,889

74,379

-102,920

-169,348

-

-

-

-

-

-

-

-

-696,776

-697,896

-873,518

-894,126

78,547

-12,532

206,468

-126,476

168,806

121

760,830

-74,823

-192,795

-253,327

-239,156

-304,639

Cash flows from investing activities
Sales of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102,376

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investment in equity investment SAVSU

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,066,823

0

342,872

0

1,886,595

6,065,524

0

-

-

-

-

-

-

-

-

-

-

-

-

Sales/maturities of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,650,000

1,242,000

1,100,000

2,625,000

2,100,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

700

0

700

700

1,400

0

0

Costs associated with internal use software development

-

-

-

-

-

-

-

-

-

-

-

-

-

256,222

162,409

142,509

552,535

388,623

397,582

497,480

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

319,000

89,000

111,000

156,000

161,000

278,000

20,000

41,000

41,000

52,557

13,258

41,033

37,152

13,415

30,765

72,417

26,936

30,156

31,847

30,881

41,128

342,525

149,456

78,922

18,777

1,561

9,386

191,786

33,937

-20,143

148,646

976,000

47,217

36,158

14,101

29,796

13,475

Net cash used in investing activities

-14,021,000

-292,000

-12,549,000

-156,000

-161,000

-5,278,000

-1,020,000

-41,000

-41,000

-52,557

-13,258

-41,033

-37,152

-

-

-

-

-

-

-

-

-42,525

-1,929,275

-6,144,446

-18,777

-1,561

-9,386

-191,786

-33,937

20,143

-147,946

-976,000

-46,517

-35,458

-12,701

-29,796

-13,475

Cash flows from financing activities
Proceeds from note payable

-

-

-

-

-

-

-

-

-

-

-

-

1,000,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-25,458

0

25,458

0

0

300,000

175,000

225,000

250,000

270,000

350,000

Payments on equipment loan

-

4,000

4,000

4,000

-

3,000

2,000

3,000

-

2,372

2,452

8,176

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on finance lease obligations

-

2,000

3,000

4,000

-

3,000

4,000

3,000

-

3,369

3,271

4,360

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-214,926

1,070,529

823,221

-396,252

2,096,639

1,716,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock options

-213,000

793,000

416,000

185,000

-11,216,000

2,825,000

8,769,000

73,000

130,000

3,193,727

470,249

194,024

120,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received in advance of issuance of stock on warrant exercises

-

-

-

-

-

-

-

57,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of preferred stock dividends

-

-

-

-

130,000

93,000

107,000

106,000

106,000

106,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,223

-

-

55,035

24,934

3,002

0

80,592

0

0

50,458

0

0

0

0

0

0

-

-

-

-

Deferred costs paid related to potential stock issuance

-

-

-

-

-

-

-

-

-

336

436

12,828

29,400

25,000

0

66,640

20,096

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,052,635

12,127

268,767

20,017

55,035

24,934

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

13,596,230

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

267,000

743,000

409,000

177,000

-2,148,000

22,683,000

7,592,000

18,000

19,000

3,081,953

454,787

168,660

1,090,600

-

-

-

-

-

-

-

-

3,002

0

80,592

13,596,230

0

25,000

0

25,458

0

0

300,000

175,000

225,000

250,000

270,000

350,000

Net increase (decrease) in cash and cash equivalents

-14,757,000

1,588,000

-12,207,000

1,167,000

-1,724,000

18,215,000

7,133,000

369,000

370,000

3,832,285

515,908

24,707

884,100

37,243

50,114

-343,962

-510,827

-178,282

-1,544,865

924,565

433,082

-736,299

-2,627,171

-6,937,372

12,683,327

76,986

3,082

14,682

-134,955

188,949

-147,825

84,830

53,660

-3,253

-16,028

1,048

31,886

Costs incurred for capitalized internal use software not paid as of quarter end (amounts are included in liabilities)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities
Purchase of property and equipment not yet paid

-117,000

142,000

-42,000

46,000

-

-

-

-

-

22,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs from issuance of warrants (See Note 7)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Conversion of notes payable and related party accrued interest to equity, net of unamortized deferred finance costs (See Note 1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

14,180,193

-

-

-

-

-

-

-

-

-

-

-

-

Costs incurred for capitalized internal use software not paid as of quarter end (amounts are included in liabilities)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

334,640

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Option exercises for which cash not yet received as of quarter end

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,989

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for services in prior period included in liabilities at prior year-end

-

-

-

-

0

0

0

36,000

36,000

376

0

0

35,624

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of warrant liabilities to equity upon exercise

-

-

-

-

-

-

-

-

29,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of equipment with debt

-

-

-

-

0

0

0

18,000

18,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs related to security issuance not yet paid as of quarter end

-

-

-

-

-

-

-

-

-

-

-

-

7,856

-

-

-

66,640

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-